Philip L. Tong

1.3k citations
23 papers · 957 indexed · h-index 10
Topics
IL-33, ST2, and ILC Pathways (4 papers)Eosinophilic Esophagitis (3 papers)Dermatology and Skin Diseases (3 papers)

In The Last Decade

Philip L. Tong

21 papers receiving 945 citations

Peers

Philip L. Tong
Comparison fields: 5 of 97
  • Immunology 616
  • Surgery 279
  • Dermatology 223
  • Physiology 126
  • Molecular Biology 98
Replace Sandra Holzmann with:
Sandra Holzmann Austria
Evelyne Kozlowski Switzerland
Laura Jardine United Kingdom
So‐Hyang Chung South Korea
Kazumoto Katagiri Japan
Peter A. Szabo United States
Heleen D. de Koning Netherlands
Wenming Peng Germany
Jean‐Luc Perrot France
Alice Roberts United States
Philip L. Tong relative to Sandra Holzmann Austria Sandra Holzmann's profile →
Citations per field
00.5×6.6×
Sandra Holzmann · 1×
Citations per year

Countries citing papers authored by Philip L. Tong

Since Specialization
Citations

This map shows the geographic impact of Philip L. Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Tong more than expected).

Fields of papers citing papers by Philip L. Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip L. Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Tong. The network helps show where Philip L. Tong may publish in the future.

Co-authorship network of co-authors of Philip L. Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Tong. A scholar is included among the top collaborators of Philip L. Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Tong. Philip L. Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 31
5 4
6 2
7 1
8 23
9 47
10 2
11 121
12 89
13 95
14 102
15 378
16 2
17 9
18 9
19 1
20 10

About Philip L. Tong

Philip L. Tong is a scholar working on Dermatology, Biophysics and Immunology and Allergy, having authored 23 papers that have together received 957 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (4 papers), Eosinophilic Esophagitis (3 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Immunology (616 citations), Dermatology (223 citations) and Immunology and Allergy (92 citations). Philip L. Tong has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Wolfgang Weninger, Ben Roediger, Szun S. Tay, Rohit Jain, Michele A. Grimbaldeston, Andrew J. Mitchell, Barbara Fazekas de St Groth, Ryan Kyle, Graham Le Gros and Holly A. Bolton. Their work appears in journals such as Immunity, Nature Immunology and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026